Join to view full profile
6651 Main StHouston, TX 77030
Phone+1 832-834-2296
Dr. Lloyd is on Doximity
As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Thomas Lloyd is a neurologist in Houston, TX and is affiliated with multiple hospitals in the area, including Johns Hopkins Hospital and St. Luke's Health - Baylor St. Luke's Medical Center. He received his medical degree from Baylor College of Medicine and has been in practice 14 years. He specializes in neuromuscular medicine and is experienced in neuromuscular medicine and muscular dystrophy. He has more than 100 publications and over 500 citings.
Education & Training
Johns Hopkins UniversityFellowship, Neuromuscular Medicine (Neurology), 2007 - 2008- Johns Hopkins UniversityResidency, Neurology, 2004 - 2007
- Johns Hopkins UniversityInternship, Internal Medicine, 2003 - 2004
Baylor College of MedicineClass of 2003
Certifications & Licensure
TX State Medical License 2023 - 2027
MD State Medical License 2007 - 2024
American Board of Psychiatry and Neurology Neurology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory - Core EMR, Epic Systems Corporation, 2014, 2016-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014, 2016-2017
Clinical Trials
- Phase III Trial of Sirolimus in IBM Start of enrollment: 2022 Jul 01
Roles: Principal Investigator
Publications & Presentations
PubMed
- 2 citationsMyeloid dendritic cell subsets characterise muscle in patients with inclusion body myositis and correlate with the IFN-γ pathway and effector T cell markers.Raphael A Kirou, Iago Pinal-Fernandez, Maria Casal-Dominguez, Katherine Pak, Chiseko Ikenaga
Annals of the Rheumatic Diseases. 2026-07-01 - 2 citationsModifying muscle metabolic dysregulation in inclusion body myositis with pioglitazone: a single-arm trial.Brittany L Adler, Michael R Bene, Cissy Zhang, Conrad Say, Pratik Khare
Nature Communications. 2026-03-15 - 2 citationsAberrant nuclear pore complex degradation contributes to neurodegeneration in VCP disease.Sandeep Kumar Dubey, Divya Chaubey, Chiseko Ikenaga, Wen-Wen Lin, Hugo J Bellen
Neuron. 2026-03-04
Journal Articles
- TDP-43 and RNA Form Amyloid-like Myo-Granules in Regenerating MuscleEvan Lester, Thomas O Vogler, Thomas E Lloyd, Eric D Nguyen, Joshua R Wheeler, Nature
Press Mentions
Fruit Flies Reveal Mechanism Behind ALS-like DiseaseJune 11th, 2012
Grant Support
- Baylor Research Education Program in Clinical NeurosciencesBAYLOR COLLEGE OF MEDICINE2025–2030
- Neuronal cell-cycle re-entry and neurodegenerationJOHNS HOPKINS UNIVERSITY2020–2025
- Pathogenesis and treatment of sporadic Inclusion Body Myositis in mouse models.JOHNS HOPKINS UNIVERSITY2020–2025
- A Drosophila Model Of Motor Neuron Disease Using Mutations In P150 / Dynactin.National Institute Of Neurological Disorders And Stroke2008–2011
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/thomas-lloyd
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
